| 查看: 2288 | 回复: 23 | |||
[交流]
帮我分析分析是否中稿呢
|
|||
|
前段时间在IOP上投了篇文章,编辑回复如下: Thank you for your submission which will be considered for publication in *************. The reference number for your article is ********. Please quote this number in all future correspondence regarding this article. 还让填一份assignment of copyright ASSIGNMENT OF COPYRIGHT and DECLARATION OF RESPONSIBILITY 1. IOP Publishing Ltd ("the Publisher" agrees to publishManuscript title: ********************* ("The Article" written by Names of all Authors: ****************************("the Named Authors" ![]() in the following journal: **********************("the Journal" ![]() 2. Transfer of Copyright Agreement 2.1 On acceptance for publication the undersigned author(s) (“Author”) of the Article assigns exclusively to IOP worldwide copyright in the Article for the full term and for all media and formats in all material published as part of the Article, which expression includes but is not limited to the text, abstract, tables, figures and graphs, but excludes any supplementary material. 2.2 If any of the Named Authors are Government employees, on acceptance for publication the Author shall grant IOP a royalty free exclusive licence for the full term of copyright for all media and formats to do in relation to the Article all acts restricted by copyright worldwide. 2.3 On acceptance for publication the Author shall grant IOP a royalty free non-exclusive licence for the full term of copyright for all media and formats to do in relation to any supplementary material deemed to be part of the Article all acts restricted by copyright worldwide. 3. Author Rights 3.1 IOP grants the Named Authors the rights specified in 3.2 and 3.3. All such rights must be exercised for non-commercial purposes, if possible should display citation information and IOP’s copyright notice, and for electronic use best efforts must be made to include a link to the on-line abstract in the Journal. Exercise of the rights in 3.3 additionally must not use the final published IOP format but the Named Author’s own format (which may include amendments made following peer review). 3.2 The rights are: 3.2.1 To make copies of the Article (all or part) for teaching purposes; 3.2.2 To include the Article (all or part) in a research thesis or dissertation; 3.2.3 To make oral presentation of the Article (all or part) and to include a summary and/or highlights of it in papers distributed at such presentations or in conference proceedings; and 3.2.4 All proprietary rights other than copyright. 3.3 The additional rights are to: 3.3.1 Use the Article (all or part) without modification in personal compilations or publications of a Named Author’s own works (provided not created by third party publisher); 3.3.2 Include the Article (all or part) on a Named Author’s own personal web site; 3.3.3 Include the Article (all or part) on web sites of the Institution (including its repository) where a Named Author worked when research for the Article was carried out; and 3.3.4 Include the Article (all or part) on third party web sites including e-print servers, but not on other publisher’s web sites. Signature In signing this Agreement the Author represents and warrants that the Article is the original work of the Named Authors, it has not been published previously in any form (other than as permitted under clause 3.2.2 which fact has been notified to IOP in writing), all Named Authors have participated sufficiently in the conception and writing of the Article, have received the final version of the Article, agree to its submission and take responsibility for it, and submission has been approved as necessary by the authorities at the establishment where the research was carried out. The Author warrants that he/she signs this Agreement as authorised agent for all Named Authors and has the full power to enter into this Agreement and to make the grants it contains, that the Article has not been and will not be submitted to another publisher prior to withdrawal or rejection, it does not infringe any third party rights, it contains nothing libellous or unlawful, all factual statements are to the best of the Author’s knowledge true or based on valid research conducted according to accepted norms, and all required permissions have been obtained in writing. All Named Authors assert their moral rights. Author’s signature………………………………………....………….Date…………………… Signature on behalf of Institution………………………………………Date……………………. |
» 猜你喜欢
Cas 72-43-5需要30g,定制合成,能接单的留言
已经有8人回复
求助:我三月中下旬出站,青基依托单位怎么办?
已经有6人回复
北京211副教授,35岁,想重新出发,去国外做博后,怎么样?
已经有8人回复
磺酰氟产物,毕不了业了!
已经有5人回复
论文终于录用啦!满足毕业条件了
已经有25人回复
2026年机械制造与材料应用国际会议 (ICMMMA 2026)
已经有3人回复
自荐读博
已经有3人回复
不自信的我
已经有5人回复
投稿Elsevier的杂志(返修),总是在选择OA和subscription界面被踢皮球
已经有8人回复
» 本主题相关价值贴推荐,对您同样有帮助:
请大家帮我分析这个产物能不能过柱纯化呢?
已经有27人回复
麻烦大家帮我分析分析
已经有4人回复
各位大牛,帮我分析下出国公派读博,是不是离我越来越远了?
已经有27人回复
大家帮我分析下导师的答复,是不是没有什么希望,谢谢大家了!!!
已经有5人回复
这个导师是什么意思呢,大家帮我分析一下吧。
已经有46人回复
哪位高手帮我分析这张幅循环伏安曲线呢
已经有12人回复
北京和深圳,哪个好呢?请大家帮我分析下
已经有28人回复
大家帮我分析分析
已经有4人回复
【求助】大家来帮我分析下是不是要这么久
已经有14人回复
大家帮我分析一下有没有这种可能呢?谢谢
已经有13人回复
» 抢金币啦!回帖就可以得到:
16年了,来看看大家
+1/198
上海师范大学生物医用材料方向招收2026级博士研究生
+1/96
供应德国EXAKT艾卡特半导体导热散热材料三辊研磨机50 PLUS
+1/92
DNA甲基化位点定量试剂盒(qPCR版)-适合特定基因位点5mC定量检测
+1/86
上海大学昝鹏教授、军事医学研究院伯晓晨研究员/倪铭副研究员 课题组招聘博士生
+1/82
澳门大学智慧城市物联网国重“结构智能感知、健康监测与无损检测”研究方向博士后招聘
+1/79
87 年东北小哥定居苏州(沪杭亦可),诚寻携手余生的你
+1/58
香港科技大学 Abhishek Kumar Srivastava 教授课题组 招收博士生
+2/40
中国科学院大连化学物理研究所DNL0902研究组招聘博士后和职工
+1/32
北京林业大学木质素高值化利用创新团队招收2026年入学博士生
+1/27
SCI,计算机相关可以写
+1/26
南科大薛亚辉课题组诚聘离子输运、低维器件、原子力显微镜等方向“快响行动”博士生
+1/21
SCI,计算机相关可以写
+1/20
2026年黄河科技学院纳米功能材料研究所招聘
+2/16
吉林大学材料物理本科生求问调剂信息
+1/11
合肥工业大学许婷婷老师招收2026年入学博士研究生,有机/高分子合成背景
+1/7
求博导收留
+1/5
浙江大学傅杰团队(杰青)高薪招聘博士后1
+1/4
深容SCI智能体四大模块:Method, Introduction, Discussion, Abstract
+1/3
海南大学化学院—功能分子器件团队2026博士/研究助理招生
+1/1
2楼2011-03-31 15:48:33
3楼2011-03-31 16:13:08
4楼2011-03-31 16:19:31
5楼2011-03-31 16:20:59
6楼2011-03-31 16:23:04
7楼2011-03-31 16:24:25
8楼2011-03-31 16:25:06
10楼2011-03-31 17:11:57
11楼2011-03-31 20:11:42
12楼2011-04-01 09:09:11
13楼2011-04-01 09:11:12
14楼2011-04-01 09:12:57
15楼2011-04-01 09:14:24
16楼2011-04-01 09:15:28
17楼2011-04-01 09:16:10
18楼2011-04-01 09:16:47
19楼2011-04-01 09:17:31
20楼2011-04-01 09:18:25
21楼2011-04-01 09:50:16
22楼2011-04-05 12:42:01
23楼2011-04-05 21:33:45
24楼2012-11-04 11:01:26
简单回复
2011-03-31 16:54
回复









agrees to publish
回复此楼

